Eine chronische Niereninsuffizienz, auch in höherem Stadium, ist Patienten häufig unbekannt – aber warum wissen Frauen noch seltener von ihrer Erkrankung als Männer?

Zusammenfassung

Hintergrund Chronische Niereninsuffizienz (CKD) ist in der Bevölkerung ab einem Alter von 40 Jahren genauso verbreitet wie Diabetes oder koronare Herzkrankheit. Obwohl eine CKD das Risiko für Folgeerkrankungen oder vorzeitigen Tod erhöht, wissen Patienten oft nichts von ihrer Erkrankung. In einer Auswertung deutscher Daten war die Unkenntnis über eine CKD bei Frauen größer als bei Männern.

Methode Es wurden Baseline-Daten aus dem Jahr 2010 von 3305 CKD-Patienten aus deutschen Kohortenstudien und Registern ausgewertet. Eine CKD der Stadien 1–4 war nach veröffentlichten Leitlinien definiert. Das Patientenwissen über eine CKD wurde über Selbstauskunft kodiert. Der Anteil von Patienten ohne Wissen über eine CKD sowie die geschlechtsspezifische Anteilsdifferenz (jeweils mit 95 %-Konfidenzintervall) wurde nach CKD-Stadien und weiteren Komorbiditäten berechnet. Darüber hinaus wurde die Prävalenz-Ratio (PR) für die Nichtkenntnis einer CKD für Frauen im Vergleich zu Männern grob und nach Alter und weiteren Risikofaktoren adjustiert geschätzt.

Ergebnisse In den Subgruppen nach Alter, CKD-Stadium und Komorbiditäten wussten Frauen seltener von ihrer CKD als Männer. Der Anteilsunterschied im Wissen um eine CKD stieg mit höherem CKD-Stadium an und betrug im Stadium 4 21 Prozentpunkte (7,6; 34,6) zuungunsten der Frauen. Bei Patienten mit einer CKD im Stadium 3b und Bluthochdruck Grad 2 wussten 61 % der Frauen nichts von ihrer Erkrankung, verglichen mit 45 % der Männer. Das PR für die Unkenntnis einer CKD für Frauen im Vergleich zu Männern im voll-adjustierten Modell stieg von 1,08 (1,00; 1,16) bei einer CKD 3a auf 1,75 (1,14; 2,68) bei einer CKD im Stadium 4.

Folgerung Frauen wissen in allen untersuchten Subgruppen seltener von ihrer CKD als Männer. Der Geschlechtsunterschied besteht unabhängig von allen untersuchten Einflussfaktoren. Mögliche Ursachen sind unbewusste geschlechtsbezogene Unterschiede in der Versorgung (gender bias) oder in der Patient-Arzt-Kommunikation.

Abstract

Introduction Chronic kidney failure (CKD) is as common as diabetes or coronary heart disease in a population aged 40 years and older. Although CKD increases the risk of secondary diseases or premature death, patients with CKD are often unaware of their disease. In a recent analysis of German data, unawareness CKD was higher in women than in men.

Methods Baseline data from 2010 of 3,305 CKD patients from German cohort studies and registries were analyzed. Stage 1–4 CKD was defined by eGFR (estimated glomerular filtration rate) and albumin-creatinine ratio according to the KDIGO-guideline. Patient knowledge of CKD was coded according to self-report. The proportion of patients without knowledge of CKD and the sex-specific proportion difference (each with 95 % confidence interval) were calculated according to CKD stages and additional comorbidities (diabetes, hypertension, anemia, and cardiovascular disease). In addition, the prevalence ratio (PR) for not knowing about CKD was estimated for women compared to men crude and adjusted for age and other risk factors.

Results Women were less likely than men to know about their CKD in all subgroups studied by age, CKD stage, and comorbidities. The proportion difference for CKD awareness increased with higher CKD stage and was 21 percentage points (7.6; 34.6) at the expense of women in CKD stage 4. Among patients with CKD stage 3b and concomitant grade 2 hypertension, 61 % of women versus 45 % of men were unaware of their disease. The PR for CKD unawareness in women compared with men in the fully adjusted model increased from 1.08 (1.00; 1.16) in CKD stage 3a to 1.75 (1.14; 2.68) in CKD stage 4.

Conclusion Despite the presence risk factors that necessitate monitoring of renal function, less than half of patients know they have CKD stage 3b or 4. Women are less likely to be aware of their CKD in all subgroups. Possible causes are gender-related differences in primary health care (gender bias) or in patient-doctor communication.

Schlüsselwörter

chronische Niereninsuffizienz, CKD - Geschlechtsunterschiede - Unkenntnis einer Erkrankung - Prädiktoren einer CKD-Unkenntnis

Key words

chronic kidney disease, CKD - sex differences - disease unawareness - predictors of CKD unawareness

Publication History

Article published online:
04 August 2022

• Literatur

• 1 Edigi G, Schelp H. Prävalenz chronischer Krankheiten und Qualitätsindikatoren in einer Bremer Hausarztpraxis. Z Allg Med 2009; 85: 187-195
• 2 Gergei I, Klotsche J, Woitas R. et al. Chronic kidney disease in primary care in Germany. J Public Health 2017; 25: 223-230
• 3 Girndt M, Trocchi P, Scheidt-Nave C. et al. The Prevalence of Renal Failure. Results from the German Health Interview and Examination Survey for Adults, 2008-2011 (DEGS1). Dtsch Arztebl Int 2016; 113: 85-91
• 4 Tuot DS, Plantinga LC, Hsu CY. et al. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol 2011; 6: 1838-1844
• 5 Al Rahbi F, Al Salmi I. Awareness, knowledge, and perception of chronic kidney disease patients at renal medicine outpatientsʼ clinic. Saudi J Kidney Dis Transpl 2020; 31: 1351-1360
• 6 Plantinga LC, Boulware LE, Coresh J. et al. Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med 2008; 168: 2268-2275
• 7 McIntyre NJ, Fluck R, McIntyre C. et al. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Br J Gen Pract 2012; 62: e227-232
• 8 Wagner M, Wanner C, Schich M. et al. Patientʼs and physicianʼs awareness of kidney disease in coronary heart disease patients – a cross-sectional analysis of the German subset of the EUROASPIRE IV survey. BMC Nephrol 2017; 18: 321
• 9 Stolpe S, Kowall B, Scholz C. et al. Unawareness for chronic kidney disease is high in all stages, age groups and comorbidities and higher in women than in men. medRxiv 2021;
• 10 Hodlmoser S, Winkelmayer WC, Zee J. et al. Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018. PLoS One 2020; 15: e0243431
• 11 Schaeffner ES, Ebert N, Delanaye P. et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157: 471-481
• 12 Brand E, Pavenstädt H, Schmieder RE. et al. The Coronary Artery Disease and Renal Failure (CAD-REF) registry: trial design, methods, and aims. Am Heart J 2013; 166: 449-456
• 13 Dörhöfer L, Lammert A, Krane V. et al. Study design of DIACORE (DIAbetes COhoRtE) – a cohort study of patients with diabetes mellitus type 2. BMC Med Genet 2013; 14: 25
• 14 Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158: 825-830
• 15 Trocchi P, Girndt M, Scheidt-Nave C. et al. Impact of the estimation equation for GFR on population-based prevalence estimates of kidney dysfunction. BMC Nephrol 2017; 18: 341
• 16 Tangri N, Grams ME, Levey AS. et al. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. JAMA 2016; 315: 164-174
• 17 Kostev K, Lucas A, Jacob L. Frequency of Blood Pressure and Estimated Glomerular Filtration Rate Testing in Type 2 Diabetes Mellitus: A Retrospective Study with 43,509 Patients. Exp Clin Endocrinol Diabetes 2019; 127: 455-460
• 18 Jacob L, Seitz F, Kostev K. Frequency of blood pressure and estimated glomerular filtration rate monitoring in patients affected by hypertension: a retrospective study with 176 565 patients in Germany. Blood Press Monit 2018; 23: 85-90
• 19 Delanaye P, Jager KJ, Bokenkamp A. et al. CKD: A Call for an Age-Adapted Definition. J Am Soc Nephrol 2019; 30: 1785-1805
• 20 Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med 2012; 27: 520-526
• 21 Brar A, Markell M. Impact of gender and gender disparities in patients with kidney disease. Curr Opin Nephrol Hypertens 2019; 28: 178-182
• 22 Carrero JJ, Hecking M, Chesnaye NC. et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol 2018; 14: 151-164
• 23 Bidmon S, Terlutter R. Gender Differences in Searching for Health Information on the Internet and the Virtual Patient-Physician Relationship in Germany: Exploratory Results on How Men and Women Differ and Why. J Med Internet Res 2015; 17: e156
• 24 Ek S. Gender differences in health information behaviour: a Finnish population-based survey. Health Promot Int 2015; 30: 736-745
• 25 Dawson KA, Schneider MA, Fletcher PC. et al. Examining gender differences in the health behaviors of Canadian university students. J R Soc Promot Health 2007; 127: 38-44
• 26 Enzenbach C, Wicklein B, Wirkner K. et al. Evaluating selection bias in a population-based cohort study with low baseline participation: the LIFE-Adult-Study. BMC Med Res Methodol 2019; 19: 135
• 27 White 3rd AA, Stubblefield-Tave B. Some Advice for Physicians and Other Clinicians Treating Minorities, Women, and Other Patients at Risk of Receiving Health Care Disparities. J Racial Ethn Health Disparities 2017; 4: 472-479
• 28 Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med 2013; 28: 1504-1510
• 29 Banks E, Welsh J, Joshy G. et al. Comparison of cardiovascular disease risk factors, assessment and management in men and women, including consideration of absolute risk: a nationally representative cross-sectional study. BMJ Open 2020; 10: e038761
• 30 Alfredsson J, Stenestrand U, Wallentin L. et al. Gender differences in management and outcome in non-ST-elevation acute coronary syndrome. Heart 2007; 93: 1357-1362
• 31 Hao Y, Liu J, Liu J. et al. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome. Circulation 2019; 139: 1776-1785
• 32 Isorni MA, Blanchard D, Teixeira N. et al. Impact of gender on use of revascularization in acute coronary syndromes: the national observational study of diagnostic and interventional cardiac catheterization (ONACI). Catheter Cardiovasc Interv 2015; 86: E58-E65
• 33 Walli-Attaei M, Joseph P, Rosengren A. et al. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet 2020; 396: 97-109
• 34 Zhao M, Vaartjes I, Graham I. et al. Sex differences in risk factor management of coronary heart disease across three regions. Heart 2017; 103: 1587-1594
• 35 Zhao M, Woodward M, Vaartjes I. et al. Sex Differences in Cardiovascular Medication Prescription in Primary Care: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2020; 9: e014742
• 36 Bösner S, Haasenritter J, Hani MA. et al. Gender bias revisited: new insights on the differential management of chest pain. BMC Fam Pract 2011; 12: 45
• 37 Patrice C, Delpech R, Panjo H. et al. Differences based on patient gender in the management of hypertension: a multilevel analysis. J Hum Hypertens 2021;
• 38 Delpech R, Bloy G, Panjo H. et al. Physiciansʼ preventive practices: more frequently performed for male patients and by female physicians. BMC Health Serv Res 2020; 20: 331